Button Text
Pipeline
The current pipeline includes several treatments in developing for blood cancer and solid tumors.

BLA

A phase 1/2 clinical trial evaluating the safety and efficacy of catumaxomab in patients with Non-Muscle -Invasive Bladder Cancer whose tumors have recurred due to Bacillus Calmette-Guerin vaccine failure. Clinicaltrials.gove: NCT04799847

Project

Pre-clinical

IND

Phase 

 
Malignant Ascites
Gastric Cancer
Bladder Cancer
Breast & Gastric Cancer
Melanoma, SCLC
Broad Solid Tumor

LP000

LP000

LP000

LP001

LP003

LP104

BLA  re-submission to EMA in preparation. IND submission to NMPA in preparation.
SOLID TUMOR
China, Taiwan (China) and South Korea have authorized to conduct clinical trial in patients with gastric cancer peritoneal carcinomatosis. Clinicaltrials.gov: NCT04222114

Phase 

Phase 

BLA

Project

Pre-clinical

IND

NHL/DLBCL/CLL

NHL/DLBCL/CLL

Multiple Myeloma

Phase 

Phase 

HEMATOLOGIC 

MALIGNANCY

LP002

LP102

LP103

 

Phase 

 

IND

Phase 

Pre-clinical

Phase 

Target Not Disclosed

INFECTIOUS

Pre-clinical

LP105

Phase 

BLA

Project